Scientific Advisory Committee on Alternative Toxicological Methods; Announcement of Meeting; Request for Comments, 37885-37887 [2017-17036]
Download as PDF
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
sradovich on DSK3GMQ082PROD with NOTICES
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Biomedical Research Review
Subcommittee.
Date: October 17, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, Conference Room 3002, 5635
Fishers Lane, Rockville, MD 20852.
Contact Person: Philippe Marmillot, Ph.D.,
Scientific Review Officer, Extramural Project
Review Branch, National Institute on Alcohol
Abuse and Alcoholism, National Institutes of
Health, 5635 Fishers Lane, Room 2017,
Bethesda, MD 20892, 301–443–2861,
marmillotp@mail.nih.gov.
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience Review
Subcommittee.
Date: October 24, 2017.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Alcohol Abuse and
Alcoholism, Terrace Level Conference Room
508, 5635 Fishers Lane, Rockville, MD 20852.
Contact Person: Beata Buzas, Ph.D.,
Scientific Review Officer, Office of
Extramural Activities, National Institute on
Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2081, Rockville, MD 20852, 301–443–0800,
bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: August 8, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–17039 Filed 8–11–17; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:45 Aug 11, 2017
Jkt 241001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer
Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov).
A portion of the National Cancer
Advisory Board meeting will be closed
to the public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Advisory Board.
Date: September 12, 2017.
Open: 1:00 p.m. to 2:55 p.m.
Agenda: Acting Director’s and program
reports and presentations; business of the
Board.
Closed: 3:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Room
TE406 & 408, Rockville, MD 20850 (Virtual
Meeting).
Contact Person: Paulette S. Gray, Ph.D.,
Executive Secretary, Division of Extramural
Activities, National Cancer Institute—Shady
Grove, National Institutes of Health, 9609
Medical Center Drive, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NCI-Shady Grove campus. Visitors
will be asked to show one form of
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
37885
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: NCAB: https://
deainfo.nci.nih.gov/advisory/ncab/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 8, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–17037 Filed 8–11–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Scientific Advisory Committee on
Alternative Toxicological Methods;
Announcement of Meeting; Request
for Comments
This notice announces a
meeting of the Scientific Advisory
Committee on Alternative Toxicological
Methods (SACATM). SACATM advises
the Interagency Coordinating Committee
on the Validation of Alternative
Methods (ICCVAM), the National
Toxicology Program (NTP) Interagency
Center for the Evaluation of Alternative
Toxicological Methods (NICEATM), and
the Director of the National Institute of
Environmental Health Sciences (NIEHS)
and NTP regarding statutorily mandated
duties of ICCVAM and activities of
NICEATM. The meeting is open to the
public, and registration is requested for
both public attendance and oral
comment and required to access the
webcast. Information about the meeting
and registration is available at https://
ntp.niehs.nih.gov/go/32822.
DATES:
Meeting: September 18–19, 2017; it
begins 9:00 a.m. Eastern Daylight Time
(EDT) each day and continues until
adjournment.
Written Public Comment
Submissions: Deadline is September 11,
2017.
Registration for Oral Comments:
Deadline is September 11, 2017.
Registration for the meeting and to
View Webcast: Deadline is September
19, 2017.
SUMMARY:
E:\FR\FM\14AUN1.SGM
14AUN1
sradovich on DSK3GMQ082PROD with NOTICES
37886
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices
Registration to view the meeting via
the webcast is required.
ADDRESSES:
Meeting Location: Natcher Conference
Center, Building 45, Room E1 & E2,
National Institutes of Health, Bethesda,
MD 20984.
Meeting Web page: The preliminary
agenda, registration information, and
background materials should be posted
at https://ntp.niehs.nih.gov/go/32822 by
August 15, 2017.
Webcast: The meeting will be
webcast; the URL will be provided to
those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary Wolfe, Designated Federal Official
for SACATM, Office of Liaison, Policy,
and Review, Division of NTP, NIEHS,
P.O. Box 12233, K2–03, Research
Triangle Park, NC 27709. Phone: 919–
541–7539, fax: 301–451–6890, email:
wolfe@niehs.nih.gov. Hand Deliver/
Courier address: 530 Davis Drive, Room
K2130, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
Preliminary Agenda and Other
Meeting Information: A preliminary
agenda, roster of SACATM members,
and background materials should be
available by August 15, 2017, on the
SACATM meeting Web site (https://
ntp.niehs.nih.gov/go/32822) and
available upon request from the
Designated Federal Official. Public
comments and any additional
information will be posted when
available. The meeting’s agenda will
focus on the US strategic roadmap for
implementation of new approaches to
safety evaluation, which is under
development, and ICCVAM agencies’
activities related to the development
and implementation of alternative
methods. Following the meeting,
summary minutes will be prepared and
available on the SACATM Web site or
upon request from the Designated
Federal Official.
Meeting and Registration: This
meeting is open to the public with time
scheduled for oral public comments.
The public may attend the meeting at
Natcher Conference Center, where
attendance is limited only by the space
available, or view the webcast.
Registration is required to view the
webcast; the URL for the webcast will be
provided in the email confirming
registration. Individuals who plan to
attend and/or provide oral comments
are encouraged to register at https://
ntp.niehs.nih.gov/go/32822 by
September 11, 2017, to facilitate
planning for the meeting. Individuals
are encouraged to access the Web site to
stay abreast of the most current
information regarding the meeting.
VerDate Sep<11>2014
16:45 Aug 11, 2017
Jkt 241001
Visitor information for those attending
in person is available at https://
www.nih.gov/about-nih/visitorinformation. Campus access and
security information is located at
https://www.nih.gov/about-nih/visitorinformation/campus-access-security.
Individuals with disabilities who need
accommodation to participate in this
event should contact Ms. Robbin Guy at
phone: 919–541–4363 or email: guyr2@
niehs.nih.gov. TTY users should contact
the Federal TTY Relay Service at 800–
877–8339. Requests should be made at
least five business days in advance of
the event.
Request for Comments: Both written
and oral public input on the agenda
topics is invited. Written comments
submitted in response to this notice
should be received by September 11,
2017. Comments will be posted on the
SACATM meeting Web site and persons
submitting them will be identified by
their name and affiliation and/or
sponsoring organization, if applicable.
Persons submitting written comments
should include their name, affiliation (if
applicable), and sponsoring
organization (if any) with the document.
Guidelines for public comments are at
https://ntp.niehs.nih.gov/ntp/about_ntp/
guidelines_public_comments_508.pdf.
Time is allotted during the meeting
for the public to present oral comments
on the agenda topics. Public comments
can be presented in-person at the
meeting or by teleconference line. There
are 50 lines for this call; availability is
on a first-come, first-served basis. The
lines will be open from 9:00 a.m. until
adjournment on September 18 and 19;
although SACATM will receive public
comments only during the formal public
comment periods, as indicated on the
preliminary agenda. Each organization
is allowed one time slot per agenda
topic. Each speaker is allotted at least 7
minutes, which if time permits, may be
extended to 10 minutes at the discretion
of the SACATM chair.
Persons wishing to present oral
comments are encouraged to register
using the SACATM meeting registration
form (https://ntp.niehs.nih.gov/go/32822)
by September 11, 2017. Registrants
should indicate the topic(s) on which
they plan to comment and whether they
will present comments in-person or via
the teleconference. The access number
for the teleconference line for public
comments will be provided to
registrants by email prior to the meeting.
Registrants are requested to, if possible,
send a copy of their statement to wolfe@
niehs.nih.gov by September 11, 2017, to
enable review by SACATM, NICEATM,
ICCVAM, and NIEHS/NTP staff prior to
the meeting. Written statements can
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
supplement and may expand the oral
presentation. Registration for on-site
oral comments will also be available on
the meeting day, although time allowed
for comments by these registrants may
be limited and will be determined by
the number of persons who register at
the meeting. If registering on-site and
reading from written text, please bring
30 copies of the statement for
distribution and to supplement the
record.
Background Information on ICCVAM,
NICEATM, and SACATM: ICCVAM is
an interagency committee composed of
representatives from 16 federal
regulatory and research agencies that
require, use, generate, or disseminate
toxicological and safety testing
information. ICCVAM conducts
technical evaluations of new, revised,
and alternative safety testing methods
with regulatory applicability and
promotes the scientific validation and
regulatory acceptance of toxicological
and safety-testing methods that more
accurately assess the safety and hazards
of chemicals and products and that
reduce, refine (decrease or eliminate
pain and distress), or replace animal
use. The ICCVAM Authorization Act of
2000 (42 U.S.C. 285l-3) established
ICCVAM as a permanent interagency
committee of the NIEHS under
NICEATM.
NICEATM administers ICCVAM,
provides scientific and operational
support for ICCVAM-related activities,
and conducts independent validation
studies to assess the usefulness and
limitations of new, revised, and
alternative test methods and strategies.
NICEATM and ICCVAM work
collaboratively to evaluate new and
improved test methods and strategies
applicable to the needs of U.S. Federal
agencies. NICEATM and ICCVAM
welcome the public nomination of new,
revised, and alternative test methods
and strategies for validation studies and
technical evaluations. Additional
information about ICCVAM and
NICEATM can be found at https://
ntp.niehs.nih.gov/go/iccvam and https://
ntp.niehs.nih.gov/go/niceatm.
SACATM was established in response
to the ICCVAM Authorization Act
[Section 285l-3(d)] and is composed of
scientists from the public and private
sectors. SACATM advises ICCVAM,
NICEATM, and the Director of the
NIEHS and NTP regarding statutorily
mandated duties of ICCVAM and
activities of NICEATM. SACATM
provides advice on priorities and
activities related to the development,
validation, scientific review, regulatory
acceptance, implementation, and
national and international
E:\FR\FM\14AUN1.SGM
14AUN1
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices
harmonization of new, revised, and
alternative toxicological test methods.
Additional information about SACATM,
including the charter, roster, and
records of past meetings, can be found
at https://ntp.niehs.nih.gov/go/167.
Dated: August 1, 2017.
John R. Bucher,
Associate Director, National Toxicology
Program.
Dated: August 8, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HOMELAND
SECURITY
[FR Doc. 2017–17040 Filed 8–11–17; 8:45 am]
[Docket No. USCG–2017–0194]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–17036 Filed 8–11–17; 8:45 am]
Substance Abuse and Mental Health
Services Administration
BILLING CODE 4140–01–P
37887
Coast Guard
Waterway Suitability Assessment for
Operation of Liquefied Hazardous Gas
Terminal; Port Arthur, TX
Coast Guard, DHS.
Notice and request for
comments.
AGENCY:
ACTION:
In accordance with Coast
Guard regulations, Lynx Terminals LLC
(Lynx Terminals) has submitted a Letter
of Intent and Preliminary Waterway
Suitability Assessment to the Coast
Guard Captain of the Port, Port Arthur,
TX (COTP) regarding the company’s
plans to handle and transport Liquefied
Hazardous Gas (LHG) at the Port of Port
Arthur docks in Port Arthur, TX. The
Coast Guard is notifying the public of
this proposed increase in LHG marine
traffic on the Sabine-Neches Waterway
and is soliciting comments relevant to
the Coast Guard’s preparation of a Letter
of Recommendation (LOR) for issue to
the federal, state or local agency with
jurisdiction over the proposed facility.
DATES: Comments and related material
must be received on or before
September 13, 2017.
ADDRESSES: You may submit comments
identified by docket number USCG–
2017–0194 using the Federal
eRulemaking Portal at https://
www.regulations.gov. See the ‘‘Public
Participation and Request for
Comments’’ portion of the
SUPPLEMENTARY INFORMATION section
below for further instructions on
submitting comments.
FOR FURTHER INFORMATION CONTACT: If
you have questions on this notice, call
or email Commander Loan T. O’Brien,
U.S. Coast Guard; telephone 409–723–
6564, email: Loan.T.O’Brien@uscg.mil.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel NIAID Clinical Trial
Planning Grant (R34), Implementation
Cooperative Agreement (U01) and SBIR
Phase II Implementation Cooperative
Agreement (U44).
Date: September 12, 2017.
Time: 10:00 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer Scientific
Review Program Division of Extramural
Activities, National Institutes of Health/
NIAID, 5601 Fishers Lane, Rockville, MD
20852, 240–669–5026, haririmf@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
VerDate Sep<11>2014
16:45 Aug 11, 2017
Jkt 241001
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention
(CSAP) National Advisory Council will
meet on August 25, 2017, 10:00 a.m.–
11:00 a.m., in Rockville, MD.
The meeting will include the review,
discussion, and evaluation of grant
applications reviewed by the Initial
Review Group, and involve an
examination of confidential financial
and business information as well as
personal information concerning the
applicants. Therefore, this meeting will
be closed to the public as determined by
the Acting Deputy Assistant Secretary
for Mental Health and Substance Use, in
accordance with Title 5 U.S.C.
552b(c)(4) and (c)(6) and 5 U.S.C. App.
2, Section 10(d).
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention National Advisory
Council.
Date/Time/Type: August 25, 2017,
10:00 a.m.–11:00 a.m. (Closed).
Place: SAMHSA Building, 5600
Fishers Lane, Rockville, MD 20852.
Contact: Matthew J. Aumen,
Designated Federal Officer, SAMHSA/
CSAP National Advisory Council, 5600
Fishers Lane, Rockville, MD 20852,
Email: Matthew.Aumen@
samhsa.hhs.gov.
Carlos R. Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017–17074 Filed 8–11–17; 8:45 am]
BILLING CODE 4162–20–P
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Public Participation and Request for
Comments
We encourage you to submit
comments and related material in
response to this notice through the
Federal eRulemaking Portal at https://
www.regulations.gov. We will consider
all submissions and may adjust our final
action based on your comments. If you
submit a comment, please include the
docket number for this notice, indicate
the specific section of this document to
which each comment applies, and
provide a reason for each suggestion or
recommendation.
We encourage you to submit
comments through the Federal
E:\FR\FM\14AUN1.SGM
14AUN1
Agencies
[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Pages 37885-37887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17036]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Scientific Advisory Committee on Alternative Toxicological
Methods; Announcement of Meeting; Request for Comments
SUMMARY: This notice announces a meeting of the Scientific Advisory
Committee on Alternative Toxicological Methods (SACATM). SACATM advises
the Interagency Coordinating Committee on the Validation of Alternative
Methods (ICCVAM), the National Toxicology Program (NTP) Interagency
Center for the Evaluation of Alternative Toxicological Methods
(NICEATM), and the Director of the National Institute of Environmental
Health Sciences (NIEHS) and NTP regarding statutorily mandated duties
of ICCVAM and activities of NICEATM. The meeting is open to the public,
and registration is requested for both public attendance and oral
comment and required to access the webcast. Information about the
meeting and registration is available at https://ntp.niehs.nih.gov/go/32822.
DATES:
Meeting: September 18-19, 2017; it begins 9:00 a.m. Eastern
Daylight Time (EDT) each day and continues until adjournment.
Written Public Comment Submissions: Deadline is September 11, 2017.
Registration for Oral Comments: Deadline is September 11, 2017.
Registration for the meeting and to View Webcast: Deadline is
September 19, 2017.
[[Page 37886]]
Registration to view the meeting via the webcast is required.
ADDRESSES:
Meeting Location: Natcher Conference Center, Building 45, Room E1 &
E2, National Institutes of Health, Bethesda, MD 20984.
Meeting Web page: The preliminary agenda, registration information,
and background materials should be posted at https://ntp.niehs.nih.gov/go/32822 by August 15, 2017.
Webcast: The meeting will be webcast; the URL will be provided to
those who register for viewing.
FOR FURTHER INFORMATION CONTACT: Dr. Mary Wolfe, Designated Federal
Official for SACATM, Office of Liaison, Policy, and Review, Division of
NTP, NIEHS, P.O. Box 12233, K2-03, Research Triangle Park, NC 27709.
Phone: 919-541-7539, fax: 301-451-6890, email: wolfe@niehs.nih.gov.
Hand Deliver/Courier address: 530 Davis Drive, Room K2130, Morrisville,
NC 27560.
SUPPLEMENTARY INFORMATION:
Preliminary Agenda and Other Meeting Information: A preliminary
agenda, roster of SACATM members, and background materials should be
available by August 15, 2017, on the SACATM meeting Web site (https://ntp.niehs.nih.gov/go/32822) and available upon request from the
Designated Federal Official. Public comments and any additional
information will be posted when available. The meeting's agenda will
focus on the US strategic roadmap for implementation of new approaches
to safety evaluation, which is under development, and ICCVAM agencies'
activities related to the development and implementation of alternative
methods. Following the meeting, summary minutes will be prepared and
available on the SACATM Web site or upon request from the Designated
Federal Official.
Meeting and Registration: This meeting is open to the public with
time scheduled for oral public comments. The public may attend the
meeting at Natcher Conference Center, where attendance is limited only
by the space available, or view the webcast. Registration is required
to view the webcast; the URL for the webcast will be provided in the
email confirming registration. Individuals who plan to attend and/or
provide oral comments are encouraged to register at https://ntp.niehs.nih.gov/go/32822 by September 11, 2017, to facilitate
planning for the meeting. Individuals are encouraged to access the Web
site to stay abreast of the most current information regarding the
meeting. Visitor information for those attending in person is available
at https://www.nih.gov/about-nih/visitor-information. Campus access and
security information is located at https://www.nih.gov/about-nih/visitor-information/campus-access-security. Individuals with
disabilities who need accommodation to participate in this event should
contact Ms. Robbin Guy at phone: 919-541-4363 or email:
guyr2@niehs.nih.gov. TTY users should contact the Federal TTY Relay
Service at 800-877-8339. Requests should be made at least five business
days in advance of the event.
Request for Comments: Both written and oral public input on the
agenda topics is invited. Written comments submitted in response to
this notice should be received by September 11, 2017. Comments will be
posted on the SACATM meeting Web site and persons submitting them will
be identified by their name and affiliation and/or sponsoring
organization, if applicable. Persons submitting written comments should
include their name, affiliation (if applicable), and sponsoring
organization (if any) with the document. Guidelines for public comments
are at https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf.
Time is allotted during the meeting for the public to present oral
comments on the agenda topics. Public comments can be presented in-
person at the meeting or by teleconference line. There are 50 lines for
this call; availability is on a first-come, first-served basis. The
lines will be open from 9:00 a.m. until adjournment on September 18 and
19; although SACATM will receive public comments only during the formal
public comment periods, as indicated on the preliminary agenda. Each
organization is allowed one time slot per agenda topic. Each speaker is
allotted at least 7 minutes, which if time permits, may be extended to
10 minutes at the discretion of the SACATM chair.
Persons wishing to present oral comments are encouraged to register
using the SACATM meeting registration form (https://ntp.niehs.nih.gov/go/32822) by September 11, 2017. Registrants should indicate the
topic(s) on which they plan to comment and whether they will present
comments in-person or via the teleconference. The access number for the
teleconference line for public comments will be provided to registrants
by email prior to the meeting. Registrants are requested to, if
possible, send a copy of their statement to wolfe@niehs.nih.gov by
September 11, 2017, to enable review by SACATM, NICEATM, ICCVAM, and
NIEHS/NTP staff prior to the meeting. Written statements can supplement
and may expand the oral presentation. Registration for on-site oral
comments will also be available on the meeting day, although time
allowed for comments by these registrants may be limited and will be
determined by the number of persons who register at the meeting. If
registering on-site and reading from written text, please bring 30
copies of the statement for distribution and to supplement the record.
Background Information on ICCVAM, NICEATM, and SACATM: ICCVAM is an
interagency committee composed of representatives from 16 federal
regulatory and research agencies that require, use, generate, or
disseminate toxicological and safety testing information. ICCVAM
conducts technical evaluations of new, revised, and alternative safety
testing methods with regulatory applicability and promotes the
scientific validation and regulatory acceptance of toxicological and
safety-testing methods that more accurately assess the safety and
hazards of chemicals and products and that reduce, refine (decrease or
eliminate pain and distress), or replace animal use. The ICCVAM
Authorization Act of 2000 (42 U.S.C. 285l-3) established ICCVAM as a
permanent interagency committee of the NIEHS under NICEATM.
NICEATM administers ICCVAM, provides scientific and operational
support for ICCVAM-related activities, and conducts independent
validation studies to assess the usefulness and limitations of new,
revised, and alternative test methods and strategies. NICEATM and
ICCVAM work collaboratively to evaluate new and improved test methods
and strategies applicable to the needs of U.S. Federal agencies.
NICEATM and ICCVAM welcome the public nomination of new, revised, and
alternative test methods and strategies for validation studies and
technical evaluations. Additional information about ICCVAM and NICEATM
can be found at https://ntp.niehs.nih.gov/go/iccvam and https://ntp.niehs.nih.gov/go/niceatm.
SACATM was established in response to the ICCVAM Authorization Act
[Section 285l-3(d)] and is composed of scientists from the public and
private sectors. SACATM advises ICCVAM, NICEATM, and the Director of
the NIEHS and NTP regarding statutorily mandated duties of ICCVAM and
activities of NICEATM. SACATM provides advice on priorities and
activities related to the development, validation, scientific review,
regulatory acceptance, implementation, and national and international
[[Page 37887]]
harmonization of new, revised, and alternative toxicological test
methods. Additional information about SACATM, including the charter,
roster, and records of past meetings, can be found at https://ntp.niehs.nih.gov/go/167.
Dated: August 1, 2017.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2017-17036 Filed 8-11-17; 8:45 am]
BILLING CODE 4140-01-P